7 Patents
- US125838622026Bifunctional Compounds for Degrading BTK via Ubiquitin Proteosome Pathway
NURIX THERAPEUTICS, Inc.
0 cites - US125288142026Bifunctional Degraders of Interleukin-1 Receptor-associated Kinases and Therapeutic Use Thereof
Gilead Sciences, Inc.
0 cites - US1248514420253-substituted Piperidine Compounds for Cbl-b Inhibition, and Use Thereof
NURIX THERAPEUTICS, Inc.
0 cites - US122342302025Substituted Benzyl-triazole Compounds for Cbl-b Inhibition, and Further Uses Thereof
NURIX THERAPEUTICS, Inc.
0 cites - US120494712024Cyano Cyclobutyl Compounds for Cbl-b Inhibition and Uses Thereof
NURIX THERAPEUTICS, Inc.
0 cites - US1195113320243-substituted Piperidine Compounds for Cbl-b Inhibition, and Use Thereof
NURIX THERAPEUTICS, Inc.
0 cites - US118664422024Bifunctional Compounds for Degrading BTK via Ubiquitin Proteosome Pathway
NURIX THERAPEUTICS, Inc.
0 cites